Continuing medical education

CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.

Advancements in Cancer Management

This program highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as: screening high-risk patients, cancer pain management, immunotherapy treatment & adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment and drug-drug interactions.

Upon completion of this activity, participants will be able to:

Explain the use of multimodal analgesia to manage pain and reduce the use of opioids
Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of patients with cancer
Evaluate immuno-oncology approaches in cancer treatment, including patient selection
Describe the appropriate follow-up protocols for identification of pulmonary nodules
Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions
Describe the various treatment options for each of the various pleural effusions

Faculty:

Kevin Tulipana, DO, FHM (Cancer Treatment Centers of America)
Stephen Lynch, MD (Cancer Treatment Centers of America)
Lorenzo Cohen, PhD (The University of Texas MD Anderson Cancer Center)
Vivek Iyer, MD (Cancer Treatment Centers of America)
Larry Ladi, MD, FCCP (Cancer Treatment Centers of America)
Timothy McCay, DO (Cancer Treatment Centers of America)
Ankur Parikh, DO (Cancer Treatment Centers of America)

Available Dates:

Ongoing

Dysphagia Palliation in Esophageal Cancer

Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.

Upon completion of this activity, participants will be able to:

Discuss the various modalities for management of dysphagia
Select the appropriate modality for management of dysphagia in patients with esophageal cancer
Explain the goals of palliative treatment in patients with esophageal cancer

Faculty:

Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
Madappa Kundranda, MD, PhD (Banner MD Anderson)

Available Dates:

Ongoing

Molecular Tumor Board Series 1

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.

Upon completion of this activity, participants will be able to:

Utilize skills learned to implement an effective tumor board.
Describe genomic testing.
Implement genomic profiling into oncology treatment.

Faculty:

Pamela Crilley, DO (Cancer Treatment Centers of America)
Ricardo H. Alvarez, MD, MSc (Cancer Treatment Centers of America)
Shayma Master Kazmi, MD, RPh (Cancer Treatment Centers of America)
Arturo Loaiza-Bonilla, MD (Cancer Treatment Centers of America)
Maurie Markman, MD (Cancer Treatment Centers of America)
Ankur R. Parikh, DO (Cancer Treatment Centers of America)
Julian Schink, MD (Cancer Treatment Centers of America)
Alan Tan, MD (Cancer Treatment Centers of America)

Available Dates:

Ongoing

Molecular Tumor Board Series 2

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sino-nasal undifferentiated carcinoma of the head & neck, and adenocarcinoma of the lung.

Upon completion of this activity, participants will be able to:

Utilize skills learned to implement an effective tumor board.
Describe genomic testing.
Implement genomic profiling into oncology treatment.

Faculty:

Shayma Maser Kazmi, MD, RPh (Cancer Treatment Centers of America)
Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
Bradford Tan, MD (Cancer Treatment Centers of America)
Scott Price, MD (Cancer Treatment Centers of America)
Pamela Crilley, DO (Cancer Treatment Centers of America)
Ankur Parikh, DO (Cancer Treatment Centers of America)
David Topolsky, MD (Cancer Treatment Centers of America)
Alan Tan, MD (Cancer Treatment Centers of America)
Maurie Markman, MD (Cancer Treatment Centers of America)
Vicki Doctor, BSN, RN (Cancer Treatment Centers of America)
Ricardo Alvarez, MD, MSc (Cancer Treatment Centers of America)
Julian Schink, MD (Cancer Treatment Centers of America)

Available Dates:

Ongoing

Molecular Tumor Board Series 3

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: colon adenocarcinoma, endometrial adenocarcinoma and breast invasive ductal carcinoma (IDC).

Upon completion of this activity, participants will be able to:

Utilize skills learned to implement an effective tumor board.
Describe genomic testing.
Implement genomic profiling into oncology treatment.

Faculty:

Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
Bradford Tan, MD (Cancer Treatment Centers of America)
Scott Price, MD (Cancer Treatment Centers of America)
Pamela Crilley, DO (Cancer Treatment Centers of America)
Ankur Parikh, DO (Cancer Treatment Centers of America)
Alan Tan, MD (Cancer Treatment Centers of America)
Maurie Markman, MD (Cancer Treatment Centers of America)
Ricardo Alvarez, MD, MSc (Cancer Treatment Centers of America)
Julian Schink, MD (Cancer Treatment Centers of America)

Available Dates:

Ongoing